Last update 01 Nov 2024
RhoVac ApS

RhoVac ApS

Subsidiary Company|
2008|
Denmark
|
10-50
|
www.rhovac.com

Overview

Tags

Neoplasms
Urogenital Diseases
Therapeutic vaccine
Synthetic peptide vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Neoplasms1
Top 5 Drug TypeCount
Therapeutic vaccine1
Synthetic peptide vaccine1

Related

1
Drugs associated with RhoVac ApS
Onilcamotide
Target-
Mechanism
Immunostimulants
Active Org.
RhoVac ApSRhoVac ApS
Originator Org.
RhoVac AB
Active Indication
Localized Prostate Carcinoma [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with RhoVac ApS
EUCTR2020-004705-31-DK / Not yet recruitingPhase 2
Long-term follow-up study of immune response to vaccinations with RV001 in patients enrolled in RhoVac-001 study
EUCTR2019-000951-14-DE / Unknown statusPhase 2
A Phase 2, Double-Blind, Placebo Controlled Study of RV001V in Men with Biochemical Failure following Curatively Intended Therapy for Localized Prostate Cancer - BRaVac
NCT04114825 / Active, not recruitingPhase 2
A Phase 2, Double-Blind, Placebo Controlled Study of RV001V in Men With Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer (BRaVac)
100 Clinical Results associated with RhoVac ApS
Login to view more data
0 Patents (Medical) associated with RhoVac ApS
Login to view more data
100 Deals associated with RhoVac ApS
Login to view more data
100 Translational Medicine associated with RhoVac ApS
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Onilcamotide
Recurrent Prostate Carcinoma
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free